Michael V. Chobotov
Keine laufenden Positionen mehr
Profil
Michael V.
Chobotov is the founder of TriVascular, Inc. (founded in 1998), Trivascular Technologies, Inc. (founded in 2007), and Trivascular2, Inc. (founded in 2011).
He held the titles of President & Chief Executive Officer, Director & Chief Technology Officer, and President, Chief Executive Officer & Director at these companies, respectively.
Dr. Chobotov is also the founder of Transmotive Technologies, Inc. He held former positions as President, Chief Executive Officer & Director at Boston Scientific Corp.
(2008-2012), Director, Senior VP-Research & Development at US Electricar, Inc., and Systems Engineer at Hughes Aircraft Co. He also served as Chief Technology Officer at Endologix LLC from 2016 to 2021 and as a Venture Partner at Kearny Venture Partners.
Dr. Chobotov received his undergraduate, graduate, and doctorate degrees from the California Institute of Technology.
Ehemalige bekannte Positionen von Michael V. Chobotov
| Unternehmen | Position | Ende |
|---|---|---|
| ENDOLOGIX, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.02.2021 |
TriVascular, Inc.
 TriVascular, Inc. Medical SpecialtiesHealth Technology TriVascular, Inc. develops and manufactures medical devices. It provides devices and procedures for treating abdominal aortic aneurysms and endovascular grafts. The company was founded by Michael V. Chobotov, Robert G. Whirley, and Joseph W. Humphrey in 1998 and is headquartered in Irvine, CA. | Vorstandsvorsitzender | 01.02.2016 |
| BOSTON SCIENTIFIC CORPORATION | Vorstandsvorsitzender | 01.01.2012 |
Trivascular2, Inc.
 Trivascular2, Inc. Medical SpecialtiesHealth Technology Trivascular2, Inc. has pioneered numerous design and manufacturing technologies in pursuit of its commitment to providing optimal solutions for endovascular aortic repair (EVAR). TriVascular's initial product offerings are novel endovascular grafts focused on significantly advancing EVAR. Building upon partnerships with thought leading clinicians worldwide, its products are designed to address unmet clinical needs and expand the pool of patients who are candidates for EVAR. Based in Santa Rosa, California, TriVascular offers highly talented, motivated individuals the opportunity to positively impact global healthcare. | Gründer | 02.12.2011 |
| Transmotive Technologies, Inc. | Gründer | - |
Ausbildung von Michael V. Chobotov
| California Institute of Technology | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| BOSTON SCIENTIFIC CORPORATION | Health Technology |
| Private Unternehmen | 8 |
|---|---|
Kearny Venture Partners
 Kearny Venture Partners Investment ManagersFinance Kearny Venture Partners (Kearny Venture Partners) is a venture capital firm. The firm is headquartered in San Francisco, California. | Finance |
| Hughes Aircraft Co. | Electronic Technology |
Trivascular2, Inc.
Trivascular2, Inc. Medical SpecialtiesHealth Technology Trivascular2, Inc. has pioneered numerous design and manufacturing technologies in pursuit of its commitment to providing optimal solutions for endovascular aortic repair (EVAR). TriVascular's initial product offerings are novel endovascular grafts focused on significantly advancing EVAR. Building upon partnerships with thought leading clinicians worldwide, its products are designed to address unmet clinical needs and expand the pool of patients who are candidates for EVAR. Based in Santa Rosa, California, TriVascular offers highly talented, motivated individuals the opportunity to positively impact global healthcare. | Health Technology |
Trivascular Technologies, Inc.
 Trivascular Technologies, Inc. Medical SpecialtiesHealth Technology Trivascular Technologies, Inc. operates as a medical device company developing and commercializing technologies to significantly advance minimally invasive treatment of abdominal aortic aneurysms. The company was founded on July 11, 2007 and is headquartered in Santa Rosa, CA. | Health Technology |
Endologix LLC
 Endologix LLC Medical SpecialtiesHealth Technology Endologix LLC engages in the research, development, manufacture, and trade of medical devices for the treatment of aortic disorders such as abdominal aortic aneurysms (AAA). Its products include AFX Endovascular AAA System, Nellix and Ovation. The company was founded in March 1992 and is headquartered in Irvine, CA. | Health Technology |
US Electricar, Inc.
 US Electricar, Inc. Motor VehiclesConsumer Durables US Electricar, Inc. manufactures electric vehicles. The private company is based in Santa Rosa, CA and has subsidiaries in United States. | Consumer Durables |
TriVascular, Inc.
TriVascular, Inc. Medical SpecialtiesHealth Technology TriVascular, Inc. develops and manufactures medical devices. It provides devices and procedures for treating abdominal aortic aneurysms and endovascular grafts. The company was founded by Michael V. Chobotov, Robert G. Whirley, and Joseph W. Humphrey in 1998 and is headquartered in Irvine, CA. | Health Technology |
| Transmotive Technologies, Inc. |
